Veradermics MANE G&A
G&A at other companies
Other financials
Where this comes from
Reported directly by Veradermics in its filing.
Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.
The official record: Veradermics ’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Veradermics 's g&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Veradermics 's G&A?
- Veradermics (MANE) reported G&A of $8.94M in Q1 2026.
- How has Veradermics 's G&A changed year-over-year?
- Veradermics 's G&A increased by 508.8% year-over-year, from $1.47M to $8.94M.
- What does G&A mean?
- The overhead costs required to run the company's administrative functions.
- How do you interpret G&A?
- An increase may signal scaling of corporate infrastructure, while a decrease often reflects improved operational efficiency or cost-containment measures.
- How does G&A compare across companies?
- Peers in the early-stage biotech sector often maintain lean G&A structures to preserve capital for R&D.